North America Superdisintegrants Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. North America Superdisintegrants Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. North America Superdisintegrants Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. North America Superdisintegrants Market Regional Analysis

6.2 North America Superdisintegrants Market Revenue 2017-2027 (US$ Million)

6.3 North America Superdisintegrants Market Forecast Analysis

7. North America Superdisintegrants Market Analysis – by Type

7.1 Synthetic Superdisintegrants

7.1.1 Overview
7.1.2 Synthetic Superdisintegrants: North America Superdisintegrants Market – Revenue and Forecast, 2017-2027 (US$ Million)

7.2 Natural Superdisintegrants

7.2.1 Overview
7.2.2 Natural Superdisintegrants: North America Superdisintegrants Market – Revenue and Forecast, 2017-2027 (US$ Million)

7.3 Other Superdisintegrants

7.3.1 Overview
7.3.2 Other Superdisintegrants: North America Superdisintegrants Market – Revenue and Forecast, 2017-2027 (US$ Million)

8. North America Superdisintegrants Market Analysis – by Formulation

8.1 Tablets

8.1.1 Overview
8.1.2 Tablets: North America Superdisintegrants Market – Revenue and Forecast, 2017-2027 (US$ Million)

8.2 Capsules

8.2.1 Overview
8.2.2 Capsules: North America Superdisintegrants Market – Revenue and Forecast, 2017-2027 (US$ Million)

9. North America Superdisintegrants Market Analysis – by Therapeutic Area

9.1 Neurological Diseases

9.1.1 Overview
9.1.2 Neurological Diseases: North America Superdisintegrants Market – Revenue and Forecast, 2017-2027 (US$ Million)

9.2 Gastrointestinal Diseases

9.2.1 Overview
9.2.2 Gastrointestinal Diseases: North America Superdisintegrants Market – Revenue and Forecast, 2017-2027 (US$ Million)

9.3 Oncology

9.3.1 Overview
9.3.2 Oncology: North America Superdisintegrants Market – Revenue and Forecast, 2017-2027 (US$ Million)

9.4 Inflammatory Diseases

9.4.1 Overview
9.4.2 Inflammatory Diseases: North America Superdisintegrants Market – Revenue and Forecast, 2017-2027 (US$ Million)

9.5 Infectious Diseases

9.5.1 Overview
9.5.2 Infectious Diseases: North America Superdisintegrants Market – Revenue and Forecast, 2017-2027 (US$ Million)

9.6 Cardiovascular Diseases

9.6.1 Overview
9.6.2 Cardiovascular Diseases: North America Superdisintegrants Market – Revenue and Forecast, 2017-2027 (US$ Million)

9.7 Other Diseases

9.7.1 Overview
9.7.2 Other Diseases: North America Superdisintegrants Market – Revenue and Forecast, 2017-2027 (US$ Million)

10. North America Superdisintegrants Market – North America Analysis

10.1 Overview

10.2 North America

10.2.1 North America Superdisintegrants Market Breakdown, by Key Country, 2020 and 2027 (%)
10.2.1.1 North America Superdisintegrants Market – Revenue and Forecast Analysis – by Country
10.2.1.1 US: North America Superdisintegrants Market – Revenue and Forecast to 2027 (US$ Million)

10.2.1.1.1 US: North America Superdisintegrants Market Breakdown, by Type
10.2.1.1.2 US: North America Superdisintegrants Market Breakdown, by Formulation
10.2.1.1.3 US: North America Superdisintegrants Market Breakdown, by Therapeutic Area

10.2.1.2 Canada: North America Superdisintegrants Market – Revenue and Forecast to 2027 (US$ Million)

10.2.1.2.1 Canada: North America Superdisintegrants Market Breakdown, by Type
10.2.1.2.2 Canada: North America Superdisintegrants Market Breakdown, by Formulation
10.2.1.2.3 Canada: North America Superdisintegrants Market Breakdown, by Therapeutic Area

10.2.1.3 Mexico : North America Superdisintegrants Market – Revenue and Forecast to 2027 (US$ Million)

10.2.1.3.1 Mexico : North America Superdisintegrants Market Breakdown, by Type
10.2.1.3.2 Mexico : North America Superdisintegrants Market Breakdown, by Formulation
10.2.1.3.3 Mexico : North America Superdisintegrants Market Breakdown, by Therapeutic Area

11. Competitive Landscape

11.1 Heat Map Analysis

11.2 Company Positioning and Concentration

12. Industry Landscape

12.1 Overview

12.2 Market Initiative

12.3 Partnerships and Collaborations

12.4 Other Developments

13. Company Profiles

13.1 Ashland,

13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments

13.2 BASF SE

13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments

13.3 DowDupont Inc.

13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments

13.4 JRS PHARMA

13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments

13.5 COREL PHARMA CHEM

13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments

13.6 Roquette Frères

13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments

13.7 Asahi Kasei Corporation

13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments

13.8 Merck KGaA

13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments

13.9 Avantor, Inc.

13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments

13.10 DFE Pharma

13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments

14. Appendix

14.1 About Business Market Insights

14.2 List of Abbreviations

North America Superdisintegrants Market